
    
      To demonstrate that in high-risk patients with complex CAD and reduced left ventricular
      function undergoing PCI, PCI with Impella Mechanical Circulatory Support (MCS) is superior to
      PCI without Impella MCS in reducing the composite rate of all-cause death, stroke, MI or
      hospitalization for cardiovascular causes at 3-year follow-up.
    
  